Pharmacodynamics

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Reevaluation Prediction of the Effect Site Propofol Eleveld Model Using Slow and Fast Induction

Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers

Clinical Decision Support Tool for Vancomycin Dosing in Children

Single Ascending Dose and Multiple Ascending Dose Study of AVR-48

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR

KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts

Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products

SB17170 Phase1 Trial in Healthy Volunteer

Electrophysiological Effects of Potential QT Prolonging Drugs

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

Modeling and Application of Triple Drug Response Surface Models

Study of DTRI-031 in Healthy Volunteers